StartupsFinSMEsabout 2 hours ago
StimCardio Raises $30M Series A Funding
1 min read
Los Angeles-based medical device company StimCardio raised $30M in Series A financing led by Metis Medtech. The funds support the NeuroPulse 2 pivotal study and FDA De Novo submission for its Rhyvive wrist-worn product designed to reduce arrhythmia recurrence.
Level
Hype check
Tap to vote and see what everyone thinks.
